Cocaine-binding DNA aptamer (MN4)

The cocaine-binding DNA aptamer is a synthetic, single-stranded DNA oligonucleotide engineered to recognize and bind cocaine with high specificity and affinity [1]. The most prominent version, known as the MN4 or MNS-4.1 aptamer, was originally identified through the Systematic Evolution of Ligands by Exponential Enrichment (SELEX) process and is characterized by a three-way junction (3WJ) secondary structure [2]. This aptamer functions by undergoing a ligand-induced folding transition, where the binding of cocaine or its metabolites (such as benzoylecgonine) stabilizes the assembly of its hydrophobic binding pocket [3]. While primarily utilized as a molecular recognition element in electrochemical and fluorescent biosensors for rapid drug detection, it is also investigated for therapeutic sequestration [4]. In this context, the aptamer acts as a neutralizing agent in the bloodstream, binding cocaine molecules to prevent them from crossing the blood-brain barrier and interacting with the dopamine transporter, thereby potentially mitigating the toxic and addictive effects of the drug [5].

Other names

Cocaine aptamerMN4 aptamerMNS-4.1 aptamerCocaine-binding oligonucleotideAnti-cocaine DNA aptamer

The aptamer acts as a molecular sequestering agent that binds to cocaine molecules via a three-way junction folding mechanism, preventing the drug from reaching its biological targets in the central nervous system. In diagnostic applications, it functions via structure-switching signaling where ligand binding triggers a measurable conformational change.